Lipeng P. Liu

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020
Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations

Clinical characteristics and prognosis of myelodysplastic neoplasms with GATA2 mutations

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: July 06, 2026

Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation

Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 20, 2026

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T.

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T.

Journal: Journal for immunotherapy of cancer

Published: January 29, 2026

Pharmacokinetics, Efficacy, and Safety Profiles of Mitoxantrone Hydrochloride Liposome Plus Cytarabine in Pediatric Patients With Newly Diagnosed Acute Myeloid Leukemia.

Pharmacokinetics, Efficacy, and Safety Profiles of Mitoxantrone Hydrochloride Liposome Plus Cytarabine in Pediatric Patients With Newly Diagnosed Acute Myeloid Leukemia.

Journal: Pediatric blood & cancer

Published: January 16, 2026

Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis

Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 17, 2025

Genomic Landscape and Clinical Outcomes of Advanced Pediatric Myelodysplastic Syndromes.

Genomic Landscape and Clinical Outcomes of Advanced Pediatric Myelodysplastic Syndromes.

Journal: European journal of haematology

Published: December 16, 2025

Early BCR::ABL1 Reduction as a Predictor of Deep Molecular Response in Pediatric Chronic-Phase Chronic Myeloid Leukemia.

Early BCR::ABL1 Reduction as a Predictor of Deep Molecular Response in Pediatric Chronic-Phase Chronic Myeloid Leukemia.

Journal: Cancers

Published: November 11, 2025

Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes

Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: October 27, 2025

Novel gene variants in a rare case of SRY-negative 46, XX male syndrome with bone marrow failure by whole exome sequencing.

Novel gene variants in a rare case of SRY-negative 46, XX male syndrome with bone marrow failure by whole exome sequencing.

Journal: Blood science (Baltimore, Md.)

Published: September 28, 2025

Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia.

Relapse risk and outcome of discontinuing asparaginase in children with acute lymphoblastic leukemia.

Journal: Annals of hematology

Published: May 28, 2025

Differences in clinical and laboratory features and survival between Chinese and Western patients with myelodysplastic neoplasm

Differences in clinical and laboratory features and survival between Chinese and Western patients with myelodysplastic neoplasm

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: May 12, 2025

Development and validation of nomograms for survival prediction in Fanconi anemia.

Development and validation of nomograms for survival prediction in Fanconi anemia.

Journal: Blood science (Baltimore, Md.)

Published: January 17, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026